Trial · NCT00511355
Registered outcomes47
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 47
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Serum Concentration of Prothrombin Fragments 1 + 2 | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of D-Dimer | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Activated Protein C (APC) Resistance Ratio (Endogenous Thrombin Potential [ETP]-Based) | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). APC resistance ratio (ETP-based) measures the anticoagulation response of plasma to APC after activation of the extrinsic coagulation pathway. An increase in the ratio indicates a reduced responsiveness to APC. Each cycle consists of 28 days. |
| Primary | Serum Concentration of Clotting Factor VIIa | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of Clotting Factor VIIc | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of Clotting Factor VIII | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of Clotting Factor II | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of Antithrombin III | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of Protein S (Free) | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of Protein S (Total) | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of Protein C | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | APC Resistance Ratio (Activated Partial Thromboplastin Time [APTT]-Based) | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). APC resistance ratio (APTT-based) measures the anticoagulation response of plasma to APC after activation of the intrinsic coagulation pathway. An increase in the ratio indicates a increased responsiveness to APC. Each cycle consists of 28 days. |
| Primary | Serum Concentration of Sex Hormone Binding Globulin (SHBG) | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of C-Reactive Protein (CRP) | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of Total Cholesterol | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of High Density Lipoprotein (HDL)-Cholesterol | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of HDL2-cholesterol | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of HDL3-cholesterol | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of Low Density Lipoprotein (LDL)-Cholesterol | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
| Primary | Serum Concentration of Apolipoprotein A-1 | Baseline and Cycle 6 (between Days 15 and 21 of the cycle) | Serum samples were obtained under fasting conditions (no food or alcoholic beverages within 12 hours of serum sampling). Each cycle consists of 28 days. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00511355/registered